Form 8-K - Current report:
SEC Accession No. 0001185185-24-000851
Filing Date
2024-08-27
Accepted
2024-08-26 18:38:55
Documents
16
Period of Report
2024-08-23
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K igc20240826_8k.htm   iXBRL 8-K 38461
2 EXHIBIT 99.1 ex_718723.htm EX-99.1 7785
7 igc20240826_8kimg001.jpg GRAPHIC 4597
  Complete submission text file 0001185185-24-000851.txt   199659

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA igc-20240823.xsd EX-101.SCH 3206
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE igc-20240823_def.xml EX-101.DEF 10590
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE igc-20240823_lab.xml EX-101.LAB 19959
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE igc-20240823_pre.xml EX-101.PRE 10950
18 EXTRACTED XBRL INSTANCE DOCUMENT igc20240826_8k_htm.xml XML 2725
Mailing Address 10224 FALLS ROAD POTOMAC MD 20854
Business Address 10224 FALLS ROAD POTOMAC MD 20854 301-983-0998
IGC Pharma, Inc. (Filer) CIK: 0001326205 (see all company filings)

EIN.: 202760393 | State of Incorp.: MD | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-32830 | Film No.: 241242792
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)